Illumion
Real-time optical imaging technology for battery material research and industrial quality control.
Website: https://illumion.io/
Cover Block
From the public record
| Field | Value |
|---|---|
| Name | Illumion |
| Tagline | Real-time optical imaging technology for battery material research and industrial quality control. |
| Headquarters | Cambridge, United Kingdom |
| Founded | 2022 |
| Stage | Seed |
| Business model | Hardware + Software |
| Industry | Deeptech |
| Technology type | Hardware |
| Geography | Western Europe |
| Growth profile | Venture Scale |
| Founding team | Academic Spinout |
| Funding label | Seed |
| Total disclosed funding | ~$5,600,000 |
Links
From the public record
- Website: https://illumion.io/
- LinkedIn: https://linkedin.com/company/illumion
The Short Version
PUBLIC Illumion is a University of Cambridge spinout building optical imaging tools for battery research and industrial quality control, and it merits investor attention because it is trying to turn a laboratory method, charge photometry, into a commercial instrumentation platform for a battery sector that still struggles with slow, destructive materials testing [Cambridge Enterprise, September 2026] [Chemistry World, February 2025] [AZoM, September 2024]. Founded in 2022, the company emerged from Cambridge research associated with Dr Alice Merryweather, Dr Christoph Schnedermann, Professor Dame Clare Grey, and Professor Akshay Rao, with public sources aligning on the spinout origin even where they vary slightly on which founder is foregrounded [Cambridge Enterprise, September 2026] [University of Cambridge Energy, October 2025] [Cambridge Angels, March 2025]. Its first product, illumionONE, was launched in September 2024 as a bench-top charge photometry system for battery-materials researchers, offering operando, single-particle imaging of state-of-charge and morphology during cycling, which is the clearest point of technical differentiation in the current public record [AZoM, September 10 2024] [QD USA, retrieved 2026] [IOPscience, retrieved 2026].
The team reads like an academic spinout that has stayed close to its scientific roots: Merryweather is publicly identified as founder and Head of R&D, Grey is a Cambridge chemistry professor known for battery materials work, and Rao is a Cambridge physics professor whose group focuses on tools and materials for the energy transition [LinkedIn, retrieved 2026] [ch.cam.ac.uk, retrieved 2026] [phy.cam.ac.uk, retrieved 2026]. On financing, public disclosures indicate about $5.6 million equivalent across pre-seed and seed funding, including a £2.1 million seed round reported in late 2024 and a later £1.7 million round backed by Foresight Group and ZEISS Ventures, which suggests continued investor support for both the research product and the industrial roadmap [Cambridge Angels, March 2025] [Cambridge Independent, December 2024] [Cambridge Enterprise, October 2026]. The business model is best understood as hardware plus software, with illumionONE sold as a compact instrument that includes integrated electrochemistry and analysis capabilities, while illumionX is being positioned for industrial battery development and production use, although that second platform remains earlier in validation based on public evidence [QD USA, retrieved 2026] [illumion.io, retrieved 2026] [thecaptable.co.uk].
Over the next 12 to 18 months, the practical questions are commercial rather than purely scientific: whether Illumion can convert strong research credibility into repeat instrument sales, whether early deployments extend beyond research institutes into industrial accounts, and whether illumionX becomes a defined product rather than a roadmap category [Chemistry World, February 2025] [Cambridge Enterprise, October 2026] [Dealroom.co, retrieved 2026]. Headcount growth from five employees at the end of 2024 to eleven at the end of 2025, alongside £750.8K of cash in bank at year-end 2025, points to an early company that is building, but still operating within the constraints typical of seed-stage deeptech hardware [Endole, retrieved 2026].
Single-source, plausible -- Core company, funding, and founder facts are corroborated by Cambridge Enterprise, Cambridge Angels, University of Cambridge, and other public sources, but some product-roadmap details rely on company or single-source reporting.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Seed |
| Business Model | Hardware + Software |
| Industry / Vertical | Deeptech |
| Technology Type | Hardware |
| Geography | Western Europe |
| Growth Profile | Venture Scale |
| Founding Team | Academic Spinout |
| Funding | Seed, total disclosed ~$5,600,000 |
The Company in Brief
PUBLIC
Illumion sits in a part of climate tooling that investors tend to notice late, after a methods paper has already hardened into instrumentation demand. The company is a University of Cambridge spinout founded in 2022 in Cambridge, United Kingdom, built around an optical imaging approach for studying battery materials in operation [illumion.io] [GOV.UK] [Cambridge Enterprise, September 2026].
The founding record is clearest on the academic roots and slightly less tidy on the exact commercial formation story. Public materials identify Dr Alice Merryweather, Professor Dame Clare Grey, and Professor Akshay Rao as founders or co-founders tied to the underlying Cambridge research, while Christoph Schnedermann appears as founder and CEO in company and corporate records and was appointed an active director on September 17, 2024 [illumion.io] [ch.cam.ac.uk] [phy.cam.ac.uk] [GOV.UK].
By chronology, the company reached several visible milestones quickly. Illumion's first disclosed external financing included £650,000 of pre-seed funding before March 2025, according to a Cambridge Angels interview, followed by a £2.1 million seed round announced around November and December 2024 by Cambridge Enterprise and Cambridge Independent, led by Foresight’s Ventures team with participation from Cambridge Enterprise Ventures, Parkwalk Advisers, and Cambridge Angels [Cambridge Angels, March 2025] [Cambridge Enterprise, September 2026] [Cambridge Independent, December 2024]. The company then launched illumionONE at Faraday 2024 on September 10, 2024, marking its first public product milestone, and later announced a further £1.7 million financing in October 2026 co-led by Foresight Group and ZEISS Ventures, with existing investors and YourVC also participating [AZoM, September 2024] [Cambridge Enterprise, October 2026] [ZEISS, October 2026].
Confirmed across multiple sources -- Confirmed by company website, GOV.UK records, and Cambridge Enterprise announcements.
What They Have Built
MIXED
Illumion is selling a battery-imaging instrument first, not an abstract materials software story. Publicly described sources converge on illumionONE as a bench-top charge photometry platform for battery-materials researchers, built to observe what happens inside operating cells at single-particle resolution in real time [AZoM, September 2024] [Chemistry World, February 2025] [QD USA, retrieved 2026]. The technical claim that repeats across independent coverage is specific: the system uses optical imaging to track changes in light scattering as ions move through electrode materials during cycling, with synchronized electrochemistry data and an integrated potentiostat supporting the measurement workflow [AZoM, September 2024] [QD USA, retrieved 2026] [IOPscience, retrieved 2026].
The public record is stronger on research use than on industrial deployment. illumionONE was officially launched on September 10, 2024 at Faraday 2024, and Chemistry World reported that the first device shipped to a research institute in Germany in December 2024 [AZoM, September 2024] [Chemistry World, February 2025]. On specifications, IOPscience attributes a 530 nm illumination wavelength and 330 nm lateral resolution to the instrument, while the company site and distributor materials describe it as a standalone, plug-and-play benchtop system compatible with Li-ion and beyond Li-ion chemistries, including sodium-ion work [IOPscience, retrieved 2026] [illumion.io, retrieved 2026] [QD USA, retrieved 2026]. Those claims are directionally consistent, but the company has not disclosed a broader installed base, published pricing, or comparative throughput benchmarks in the cited public material.
A second platform, illumionX, has been publicly described, but with thinner evidence and less product detail. Cambridge Enterprise and Dealroom characterize it as an industrial-facing system in development for battery makers, intended to translate the same imaging approach into faster development cycles and better quality-control decisions on the production line [Cambridge Enterprise, October 2026] [Dealroom, retrieved 2026]. That is a credible extension of the research instrument, particularly given ZEISS Ventures' participation in the 2026 round, but the available public evidence does not yet establish commercial release, named factory deployments, or verified production-line performance [Cambridge Enterprise, October 2026] [ZEISS, October 2026].
Single-source, plausible -- Product capabilities are corroborated by multiple public sources including AZoM, Chemistry World, QD USA, and IOPscience, but illumionX remains only partially substantiated in public materials.
Market Size and Demand
PUBLIC
Battery analysis tools sit in a market that matters now because the pace of battery chemistry iteration is accelerating, while the cost of getting materials decisions wrong still compounds over multi-year development cycles [Cambridge Angels, March 2025] [University of Cambridge Energy, October 2025].
The public record here is stronger on the problem definition than on formal market sizing. No named third-party TAM, SAM, or SOM estimate for Illumion specifically appears in the cited materials, so the addressable market has to be framed through adjacent, clearly analogous demand pools rather than asserted as a precise number. The company is positioned first around battery-materials researchers and electrochemical scientists using lab instrumentation such as illumionONE, then toward industrial battery-development and quality-control teams through the in-development illumionX platform [AZoM, September 10 2024] [Cambridge Enterprise, October 2026]. That sequencing suggests an initial wedge in research instrumentation, with a possible expansion path into production and process analytics if the industrial product matures as described [Chemistry World, February 17 2025] [thecaptable.co.uk].
The clearest demand driver is time. In a March 2025 interview, CEO Christoph Schnedermann described battery-material development as a process that can take roughly a decade, with substantial trial and error along the way [Cambridge Angels, March 2025]. Illumion's pitch is that real-time, single-particle optical observation can shorten that loop by showing how ions move and how particles change during cycling, rather than forcing researchers to infer behavior from slower or destructive methods [Cambridge Independent, December 2024] [University of Cambridge Energy, October 2025] [qdusa.com]. For buyers, that is less a generic lab upgrade than a decision-speed claim: better visibility into failure modes, state-of-charge behavior, and morphology should help teams discard weak material candidates earlier and focus resources on the chemistries that merit scale-up [AZoM, September 10 2024] [sfr.ca].
The adjacent markets are broad enough to matter, but they also set a high bar. On one side sits scientific instrumentation for university labs, battery startups, and corporate R&D groups. On the other sits industrial quality control and process development in battery manufacturing, which appears to be the stated ambition for illumionX [Cambridge Enterprise, October 2026] [Dealroom.co]. Those are related but not identical markets. Research tools can win on novelty and insight density; factory-adjacent tools usually also need throughput, repeatability, integration into existing workflows, and a clearer proof that the measurement changes yield or scrap decisions. Public materials support Illumion's relevance to both domains, but only the research-side product, illumionONE, appears launched and shipped so far [AZoM, September 10 2024] [Chemistry World, February 17 2025].
Regulatory and macro forces are supportive in a general sense, even if the sources stop short of tying Illumion to any one policy regime. The company's chemistry-agnostic positioning across Li-ion and beyond-Li-ion systems, including sodium-ion, is notable because battery research is spreading beyond a single incumbent chemistry family [AZoM, September 10 2024] [illumion.io]. At the same time, sustained public and industrial attention on energy storage, battery resilience, and materials innovation raises the value of tools that can de-risk experiments earlier in the cycle [University of Cambridge Energy, October 2025] [Professor Dame Clare Grey's University of Cambridge profile is not directly about market demand, so it is not used here]. The macro caveat is straightforward: instrumentation budgets, especially in academia and pilot-stage industrial R&D, can remain cyclical and grant-dependent, which can stretch sales cycles even when technical interest is high [Cambridge Angels, March 2025].
| Market frame | Public evidence | Relevance to Illumion |
|---|---|---|
| Battery materials research instrumentation | illumionONE launched in September 2024 for battery-materials researchers and electrochemical scientists [AZoM, September 10 2024] | Near-term entry market with a shipped product and defined user base |
| Industrial battery development tools | illumionX described as a platform in development for industrial battery teams and quality-control use cases [Cambridge Enterprise, October 2026] [thecaptable.co.uk] | Expansion market, but still dependent on product execution and industrial validation |
| Beyond-Li-ion analysis workflows | illumionONE described as compatible with Li-ion and beyond-Li-ion chemistries, including Na-ion [AZoM, September 10 2024] [illumion.io] | Broadens the potential buyer universe beyond a single chemistry cycle |
The picture from public evidence is a credible wedge into battery R&D instrumentation, with a larger but less proven adjacency in industrial quality control. The market case is easier to underwrite on urgency than on size, because the sources document a costly research bottleneck clearly, while offering limited independent quantification of how much spend sits behind that bottleneck.
Single-source, plausible -- Market demand is supported by named public sources including Cambridge Angels, AZoM, Chemistry World, Cambridge Independent, qdusa.com, sfr.ca, and University of Cambridge Energy, but formal TAM/SAM/SOM figures are not independently quantified in the cited research.
Who Else Is Fighting for This
MIXED Illumion is positioned less against a clearly disclosed set of direct startup peers than against the established toolkit battery labs and industrial teams already use to study materials, which makes the near-term contest one of workflow replacement rather than category creation [AZoM, September 2024] [Chemistry World, February 2025] [Cambridge Enterprise, September 2026].
The public record is thin on named direct competitors, so the clearest competitive map starts with segments rather than logos. In research settings, illumionONE appears to sit beside incumbent analytical methods that battery scientists already know well, including microscopy and electrochemical testing workflows, with Illumion arguing that charge photometry adds real-time, single-particle visibility during cycling rather than relying only on destructive or post hoc analysis [AZoM, September 2024] [QD USA, retrieved 2026] [Cambridge Independent, December 2024]. In that sense, the main substitute is not one startup named in the sources, but the existing stack of lab instruments and methods that can answer adjacent questions with established budgets and trained users [Chemistry World, February 2025] [University of Cambridge Energy, October 2025].
For industrial battery teams, the company is trying to extend from a research instrument into a process and quality-control tool through illumionX, but that product remains described as in development rather than broadly deployed [Cambridge Enterprise, October 2026] [Dealroom.co, retrieved 2026] [thecaptable.co.uk]. That leaves Illumion competing, at least conceptually, with internal process engineering tools, incumbent metrology vendors, and production-line quality systems that already have procurement paths inside manufacturers, even if the sources do not name those vendors directly [Cambridge Enterprise, October 2026] [Cambridge Angels, March 2025].
The company does have a visible edge, and it is grounded in technical origin and scientific credibility. Illumion is a University of Cambridge spinout built on work associated with Professor Dame Clare Grey and Professor Akshay Rao, both of whom have established academic standing in battery science and energy-transition materials research [phy.cam.ac.uk, retrieved 2026] [ch.cam.ac.uk, retrieved 2026] [energy.cam.ac.uk, May 2024]. The instrument itself is described across multiple sources as a compact benchtop charge photometer with integrated electrochemistry and single-particle operando imaging, which suggests a differentiated product architecture rather than a software-only layer on top of commodity hardware [IOP Science, retrieved 2026] [QD USA, retrieved 2026] [AZoM, September 2024]. That edge should be durable in early R&D accounts if the measurement capability is genuinely hard to replicate, but it is also perishable if larger instrument vendors can package similar optical and electrochemical functionality into broader product suites before Illumion builds a meaningful installed base.
The most exposed flank is go-to-market reach. Illumion has disclosed one shipped system to a research institute in Germany as of December 2024, and the public materials point to a small team, with Endole showing 11 employees at year-end 2025 and LinkedIn showing 13 employees in 2026 [Chemistry World, February 2025] [Endole, retrieved 2026] [LinkedIn, retrieved 2026]. That is enough to suggest product progress, but not enough to show that the company yet owns a sales channel, service network, or procurement position against larger instrumentation groups. ZEISS Ventures is the one named strategic backer in the record, and if that relationship develops beyond financing it could materially strengthen credibility with industrial buyers, but the public evidence today establishes investment support, not a commercial distribution agreement [ZEISS, October 2026] [Cambridge Enterprise, October 2026].
Over the next 18 months, the most plausible competitive scenario is bifurcated. Illumion is the likely winner if battery research labs continue to prioritize operando materials insight and the company can convert its scientific novelty into repeat academic and applied R&D sales, because the current wedge is clear and the product appears designed for bench-level adoption rather than factory-wide change management [AZoM, September 2024] [Chemistry World, February 2025] [Cambridge Angels, March 2025]. Illumion is also the likely loser if industrial adoption becomes the near-term benchmark and procurement shifts toward vendors with entrenched manufacturing channels, because illumionX is still framed publicly as an emerging platform rather than a proven line solution [Cambridge Enterprise, October 2026] [Dealroom.co, retrieved 2026]. With no named direct startup rival consistently appearing in the source set, the real competitive pressure appears to come from incumbent instrumentation and process-control ecosystems that can sell completeness and support, even if they cannot yet show the same charge-photometry framing [Cambridge Enterprise, September 2026] [University of Cambridge Energy, October 2025].
Opportunity
PUBLIC
The prize here is larger than a niche lab-tool outcome: if Illumion executes across research and industrial workflows, it could become a core instrumentation and software layer for how battery materials are developed, qualified, and monitored from early science through production-line decision-making [Cambridge Enterprise, September 2026] [Cambridge Enterprise, October 2026] [AZoM, September 2024].
The clearest upside case starts with the fact pattern already on the record. Illumion is not selling a general battery narrative, it is commercializing a specific measurement method, charge photometry, that multiple public sources describe in similar terms: real-time, operando optical imaging of battery materials at single-particle resolution inside working cells [AZoM, September 2024] [Chemistry World, February 2025] [QD USA, retrieved 2026]. That matters because instrumentation companies can become durable when they introduce a new measurement primitive rather than a faster version of an existing test. Illumion also appears to have crossed the first commercialization threshold, with illumionONE launched in September 2024 and a first device shipped to a research institute in Germany in December 2024 [AZoM, September 2024] [Chemistry World, February 2025]. The second leg of the opportunity is visible, though earlier: public reporting describes illumionX as a platform in development for industrial battery teams focused on faster development cycles and quality control, which points to a much larger budget pool than academic research alone [Cambridge Enterprise, October 2026] [thecaptable.co.uk] [Dealroom.co].
That combination, a research wedge plus an industrial product path, is what makes the largest outcome reachable rather than merely interesting. The company was founded out of University of Cambridge research, with co-founders including Professor Dame Clare Grey and Professor Akshay Rao, both publicly tied to battery and energy-transition research at Cambridge [University of Cambridge Energy, May 2024] [University of Cambridge Department of Chemistry, retrieved 2026] [University of Cambridge Department of Physics, retrieved 2026]. Investors have also financed the platform more than once, including a November 2024 seed round led by Foresight's Ventures team and an October 2026 round backed by Foresight Group and ZEISS Ventures [Cambridge Enterprise, September 2026] [Cambridge Enterprise, October 2026] [ZEISS, October 2026]. For an instrumentation startup, strategic backing from an optics incumbent is not proof of market pull, but it is a meaningful signal that the technology may matter beyond a single academic niche [ZEISS, October 2026].
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Research-system standard | illumionONE becomes a recognized workbench instrument for battery-materials labs, especially for teams working on Li-ion and beyond Li-ion chemistries | More peer-reviewed use cases and additional shipments after the September 2024 launch | The platform has already launched publicly, is described as compact and bench-top by multiple sources, and has shipped at least one unit to Germany [AZoM, September 2024] [Chemistry World, February 2025] [QD USA, retrieved 2026] |
| Industrial development bridge | illumionX converts research insight into a paid workflow for battery manufacturers and development teams trying to shorten test cycles and improve QC decisions | Successful commercialization of illumionX with support from strategic investor ZEISS Ventures | Public sources describe illumionX as being developed specifically for industrial battery teams and production-line quality control use cases [Cambridge Enterprise, October 2026] [thecaptable.co.uk] [Dealroom.co] |
| Category-defining measurement stack | Illumion becomes the default platform for observing state-of-charge and morphology changes at particle level across new battery chemistries, pairing hardware sales with recurring analysis software and workflow adoption | Charge photometry gains status as a standard method in battery R&D programs | Multiple independent descriptions point to differentiated capability, real-time operando imaging with single-particle resolution and synchronized electrochemistry, which is the kind of technical edge that can anchor a new category standard [AZoM, September 2024] [IOPscience, retrieved 2026] [SFR, retrieved 2026] |
The compounding mechanism would come from method adoption rather than a classic consumer-style network effect. If illumionONE wins in research labs, each published result, internal validation workflow, and trained operator increases the cost of switching away from the method. The software layer matters here: QD USA describes acquisition and analysis software that defines electrochemical protocols, controls the integrated potentiostat, and analyzes charge-photometry data, which suggests the product is already more than a standalone optical box [QD USA, retrieved 2026]. A second compounding loop sits in chemistry breadth. Public materials describe the system as compatible with Li-ion and beyond Li-ion chemistries, including sodium-ion work, so each proof point in one chemistry family can broaden the addressable installed base without forcing an entirely new platform architecture [AZoM, September 2024] [illumion.io, retrieved 2026]. If illumionX reaches factory or pre-production workflows, distribution could compound again because process-development and quality teams tend to prefer validated tools that connect upstream R&D insight with downstream acceptance criteria [Cambridge Enterprise, October 2026].
The size of the win is best framed qualitatively because the source set here does not include a clean public comparable or a third-party market-size report that can support a disciplined valuation bridge. Even so, the shape of the upside is visible. A company that owns a category-specific measurement standard in battery R&D and then extends it into industrial development and quality control can become worth far more than a single-product hardware vendor, because revenue would sit across instrument sales, software, applications support, and replacement or expansion purchases. If the "industrial development bridge" scenario plays out, Illumion could plausibly resemble a high-value scientific instrumentation platform with strategic relevance to battery OEMs and enabling-tech incumbents, which would support venture-scale outcomes (scenario, not a forecast) [Cambridge Enterprise, September 2026] [Cambridge Enterprise, October 2026] [ZEISS, October 2026].
Single-source, plausible -- Core product, launch, shipment, founders, and funding claims are supported by named public sources including Cambridge Enterprise, AZoM, Chemistry World, QD USA, and ZEISS, but the largest upside assumptions around industrial adoption rest partly on company-linked or single-source descriptions of illumionX.
Sources
From the public record
[Cambridge Enterprise, September 2026] Illumion closes £2.1 million Seed round to further develop their cutting-edge battery technology | https://www.enterprise.cam.ac.uk/news/illumion-closes-2-1-million-seed-round-to-further-develop-their-cutting-edge-battery-technology/
[Chemistry World, February 2025] Cambridge spin-out launches charge photometer to study batteries in action | https://www.chemistryworld.com/news/cambridge-spin-out-launches-charge-photometer-to-study-batteries-in-action/4020915.article
[AZoM, September 10 2024] Illumion Unveils illumionONE at Faraday Institution Conference 2024 | https://www.azom.com/news.aspx?newsID=64093
[University of Cambridge Energy, October 2025] Start-up success for Newnham Research Fellow | https://www.energy.cam.ac.uk/news/start-success-newnham-research-fellow
[Cambridge Angels, March 2025] An Interview with Christoph Schnedermann of Illumion | https://www.cambridgeangels.com/portfolio-interviews-1/illuminating-the-future-of-battery-technology-an-interview-with-christoph-schnedermann-of-illumion
[LinkedIn, retrieved 2026] linkedin.com | https://linkedin.com/company/illumion
[ch.cam.ac.uk, retrieved 2026] Professor Dame Clare Grey | https://www.ch.cam.ac.uk/person/cpg27
[phy.cam.ac.uk, retrieved 2026] Akshay Rao | https://www.phy.cam.ac.uk/directory/raoa
[QD USA, retrieved 2026] illumionONE | https://www.qdusa.com/en/products/illumionone/
[IOPscience, retrieved 2026] Charge photometry reveals heterogeneity and phase behaviour in individual cathode particles during battery cycling | https://iopscience.iop.org/article/10.1088/2515-7655/ad5d9f
[Cambridge Independent, December 2024] Illumion’s ‘Charge Photometry’ battery charge technology receives £2.1m seed funding boost | https://www.cambridgeindependent.co.uk/business/illumion-s-charge-photometry-battery-charge-technology-receives-2-1m-seed-funding-boost-9395732/
[illumion.io] Transforming Energy Storage With Light | Illumion Ltd | https://illumion.io/
[thecaptable.co.uk] Illumion develops battery production platform | https://www.thecaptable.co.uk/news/illumion-develops-battery-production-platform
[Endole, retrieved 2026] Illumion Ltd | https://suite.endole.co.uk/insight/company/14511029-illumion-ltd
[GOV.UK, retrieved 2026] Christoph Schnedermann appointment history | https://find-and-update.company-information.service.gov.uk/officers/
[Cambridge Enterprise, October 2026] Illumion raises £1.7m to bring next-generation battery imaging technology to market | https://www.enterprise.cam.ac.uk/news/illumion-raises-1-7m-to-bring-next-generation-battery-imaging-technology-to-market
[ZEISS, October 2026] Battery imaging: ZEISS backs Illumion’s technology | https://www.zeiss.com/corporate/en/about-zeiss/present/newsroom/press-releases/2026/battery-imaging-illumion.html
[Dealroom.co, retrieved 2026] Illumion company profile | https://dealroom.co/companies/illumion
[sfr.ca, retrieved 2026] Charge photometry | https://www.sfr.ca/charge-photometry
[energy.cam.ac.uk, May 2024] Clare Grey elected as an international member of the National Academy of Sciences | https://www.energy.cam.ac.uk/news/professor-dame-clare-grey-elected-international-member-national-academy-sciences
Articles about Illumion
- A Cambridge Spinout's Microscope Watches Ions Flow Inside a Battery — The startup's optical imaging technology, born in a Cambridge lab, aims to give researchers and manufacturers a real-time view of material performance.